Latest multiple myeloma News

University of Melbourne secures more than $42m in medical research grants
Cancer Council Australia and public health leaders call for junk food marketing restrictions
Our PBS Is World-leading Scheme But It Can Be Better
Hope becomes reality for Australians with multiple myeloma
Free Multiple Myeloma Therapy Now Available
Eleven types of cancer are on the rise in England’s under 50s – these factors might explain the trend
Understanding Hodgkin lymphoma cell origins could yield better diagnostics
Cheaper Medicines For People Fighting Cancer And Rare Diseases
Masked T-cell engagers: cancer immunotherapies for the future?
Immune Cells Are Programmed Within Body To Fight Cancer
Supporting Next Gen Of Victorian Cancer Researchers
New high-performance technology provides deep insight into disease processes
New ‘Trojan Horse’ multiple myeloma treatment option now approved for eligible Australian patients
Safety Net Secured For NSW Firefighters Diagnosed With Cancer
Cheaper Cancer And Chronic Conditions Medicines Now On PBS
Strengthening safety net for firefighters affected by cancer
Rethinking myeloma: Bone marrow map reveals hidden complexity of blood cancer
Preparations for the first CAR-T treatment for multiple myeloma in routine healthcare
First patient in Sweden with multiple myeloma prepared for CAR-T therapy in routine healthcare
NSW new clinical trials crucial for life of Brian and many others
Magnetic Approach To Chemo-induced Neuropathy
Blood test could make cancer treatments safer and more effective
BrightPath Bio and Cellistic Announces Process Development and Manufacturing Collaboration for Phase 1 Clinical Trial of iPSC-derived BCMA CAR-iNKT cell
PBS Changes From 1 October
Honour And Commitment
Donations Make Difference
Blood test may guide use of multiple myeloma immunotherapy
Groundbreaking cancer treatment may trigger more cancer – but here’s why you shouldn’t worry
Race says bisantrene highly active in a mouse model of multiple myeloma
PBS Changes From 1 May 2024
Monash Partners Comprehensive Cancer Consortium awards innovation grants to propel precision cancer treatment
Acquisition Of Gracell Completed
Sowing seeds for better cancer outcomes
Practice-changing study on bone marrow cancer therapy
AstraZeneca to acquire Gracell, furthering cell therapy ambition across oncology and autoimmune diseases
Boost for life-changing medical research
New therapy target to shut down multiple myeloma’s ability to survive and thrive
Researchers chart contents of human bone marrow
HaemaLogiX Announces Appointment of Damian Clarke-Bruce as Managing Director and CEO
Dan L Duncan Comprehensive Cancer Center to open cell therapy clinical trials at Harris Health
Support For Victorian Medical Research Powers On
Disrupting a core metabolic process in T cells may improve their therapeutic efficacy
New discovery: dual acting drug delivers blood cancer a lethal ‘one-two’ punch
Vital boost to blood cancer treatment
HaemaLogiX and Peter MacCallum Cancer Centre Announce Myeloma CAR-T Phase I Clinical Trial Agreement
World-first clinical trial for blood cancer underway in the Illawarra
Funding boost advances research on cancer vaccine
Highly Cited Researchers 2022